Asthma Therapeutics Market Size, Share & Forecast to 2030

The Asthma Therapeutics Market grew from USD 24.70 billion in 2023 to USD 27.26 billion in 2024. It is expected to continue growing at a CAGR of 10.63%, reaching USD 50.10 billion by 2030.

This market serves a diverse population of patients across age groups who require either maintenance therapy or acute care for asthmatic episodes. The market scope includes various therapeutic products such as anti-inflammatory drugs, bronchodilators, combination therapies, biologics, and delivery devices such as inhalers and nebulizers. The primary applications within the asthma therapeutics market include long-term control medicines, which aim to maintain a stable condition, and quick-relief treatments for sudden symptoms. End-users of these products typically entail individuals diagnosed with asthma, healthcare professionals like pulmonologists, and healthcare settings, including hospitals, clinics, and homecare environments. The scope extends to support services like patient education and training on the proper use of asthma management devices. The need for asthma therapeutics is increasing due to growing incidences of asthma and other respiratory diseases, recent improvements in allergy detection and diagnostic technologies, and extensive demand for monoclonal antibodies. However, the asthma therapeutics market faces certain challenges, including limitations and side effects of asthma therapeutic devices, high costs associated with advanced treatments, and limited therapeutic reach in remote and rural areas. On the other hand, several opportunities are emerging within the asthma therapeutics market, including the development of combination therapeutics for the treatment and extensive research and development (R&D) efforts for asthma treatment. There is also an increasing trend towards digital health solutions, such as smart inhalers that can track usage and remind patients about doses, opening opportunities for tech companies and pharmaceutical partnerships.

Regional Insights

In the United States, the asthma therapeutics market is driven by a high prevalence of asthma alongside strong healthcare infrastructure. Patent expirations, novel biologics, and personalized medicine drive research and innovation in the region. Various organizations in the region continue to find a cure for and control asthma, food allergies, nasal allergies, and other allergic diseases. South America shows a growing need for asthma therapeutics, largely due to increasing awareness of respiratory diseases and improving healthcare facilities. Europe represents a substantial market for asthma therapeutics, supported by high awareness levels, established healthcare systems, and favorable reimbursement policies. The presence of several key market players and a strong emphasis on research and development activities are notable factors. Western European countries, including Germany, France, Switzerland, the United Kingdom, France, and Italy, hold a major market share, while Eastern European countries exhibit potential for growth due to improving healthcare infrastructure and rising asthma prevalence. The market in the Middle East is advancing with the development of healthcare infrastructure and increasing private sector investment. In contrast, Africa faces challenges such as limited healthcare services, low awareness, and inadequate access to treatment, which hinder market growth. However, certain countries, including South Africa, are making strides in asthma care, which can positively influence regional market development. In APAC, China's asthma therapeutic market is developing rapidly due to the growing middle class and enhanced healthcare reforms. In Japan, patients have access to several state-of-the-art treatments, reflecting the country's advanced healthcare system and high patient awareness. Japan's pharmaceutical sector is highly innovative, with a robust pipeline of new drugs and consistent investment in R&D. India's asthma treatment market is characterized by a need for affordable medications and increased education on asthma management. The high population, coupled with pollution issues, contributes to a growing prevalence of asthma. Government programs and non-profit initiatives aim to enhance asthma care accessibility and affordability throughout the subcontinent.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Asthma Therapeutics Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

Growing Incidences of Asthma and Other Respiratory Diseases
Recent Improvements in Allergy Detection and Diagnostic Technologies
Extensive Demand for Monoclonal Antibodies

Market Restraints

Limitation and Side Effects of Asthma Therapeutic Devices

Market Opportunities

Development of Combination Therapeutics for The Treatment
Extensive Research and Development (R&D) Efforts for Asthma Treatment

Market Challenges

Limited Therapeutics Reach in Remote & Rural Areas

Market Segmentation Analysis

Product: Rising demand for metered dose inhalers for the treatment of asthma
Drug Class: Growing usage of anti-Inflammatory drugs in asthma therapeutics
Route of administration: Expanding adoption of inhaled asthma medication for fast relief

Industry Insights

Market Disruption Analysis
Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Asthma Therapeutics Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Asthma Therapeutics Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

GSK Boosts Respiratory Portfolio with $1.4 Billion Aiolos Bio Acquisition

GlaxoSmithKline PLC has announced the acquisition of Aiolos Bio Inc. with an investment of USD 1.4 billion. This acquisition aims to enhance GSK's foothold in the asthma treatment market as this deal gives GSK access to AIO-001, a cutting-edge asthma therapy by Aiolos Bio.

Teva and Biolojic Design Announce Exclusive License Agreement for the Development of a Therapeutic Antibody for Atopic Dermatitis and Asthma

Teva Pharmaceutical Industries Ltd. and Biolojic Design Ltd. announced an exclusive license agreement to develop a potential novel antibody-based therapy for treating Atopic Dermatitis and Asthma. BD9 is novel for its dual-action mechanism that inhibits both TSLP and IL-13, offering a more comprehensive treatment option over current single-target therapies. This collaboration is a strategic move complementing Teva's 'Pivot to Growth' strategy, which was unveiled in May 2023 and focuses on stoking innovation through partnerships and enhancing Teva's early-stage pipeline.

Lupin Launches Luforbec® 100/6 for Adult Asthma and COPD Treatment

Hormosan Pharma GmbH, a fully owned subsidiary of Lupin Limited, announced the launch of Luforbec 100/6, a fixed blend in a pressurized metered dose inhaler (pMDI) for the remedy of adult chronic obstructive pulmonary disease (COPD) and asthma in Germany.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Asthma Therapeutics Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Asthma Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amgen Inc., AstraZeneca PLC, Biogen Inc., Boehringer Ingelheim GmbH, Boston Scientific Corporation, Chiesi Farmaceutici S.p.A., Cipla Limited, F. Hoffmann-La Roche Ltd, Genentech, Inc., GlaxoSmithKline PLC, Kare Medical and Analytical Devices Ltd. Co., Koninklijke Philips N.V., Lupin Limited, Medtronic PLC, Merck & Co, Inc., Merxin Ltd., Novartis AG, Parekhplast India Limited, Pfizer Inc., Regeneron Pharmaceuticals, Inc., Sanofi S.A., Shenzhen Aeon Technology Co., Ltd., Softhale NV by invoX Pharma Limited, Sun Pharmaceutical Industries Limited, Sunovion Pharmaceuticals, Inc., Takeda Pharmaceutical Company, Teva Pharmaceutical Industries Ltd., Trudell Medical Limited, Viatris Inc., and Wellinks, Inc..

Market Segmentation & Coverage

This research report categorizes the Asthma Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product- Inhalers

Dry Powder Inhalers
Metered-Dose Inhalers
Soft Mist Inhalers
Nebulizers

Drug Class

Anti-Inflammatory
Bronchodilators
Combination Therapy

Route of administration

Inhaled
Oral

Region

Americas

Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas

Asia-Pacific

Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe, Middle East & Africa

Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing Incidences of Asthma and Other Respiratory Diseases
5.1.1.2. Recent Improvements in Allergy Detection and Diagnostic Technologies
5.1.1.3. Extensive Demand for Monoclonal Antibodies
5.1.2. Restraints
5.1.2.1. Limitation and Side Effects of Asthma Therapeutic Devices
5.1.3. Opportunities
5.1.3.1. Development of Combination Therapeutics for The Treatment
5.1.3.2. Extensive Research and Development (R&D) Efforts for Asthma Treatment
5.1.4. Challenges
5.1.4.1. Limited Therapeutics Reach in Remote & Rural Areas
5.2. Market Segmentation Analysis
5.2.1. Product: Rising demand for metered dose inhalers for the treatment of asthma
5.2.2. Drug Class: Growing usage of anti-Inflammatory drugs in asthma therapeutics
5.2.3. Route of administration: Expanding adoption of inhaled asthma medication for fast relief
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization

6. Asthma Therapeutics Market, by Product

6.1. Introduction
6.2. Inhalers
6.3. Nebulizers

7. Asthma Therapeutics Market, by Drug Class

7.1. Introduction
7.2. Anti-Inflammatory
7.3. Bronchodilators
7.4. Combination Therapy

8. Asthma Therapeutics Market, by Route of administration

8.1. Introduction
8.2. Inhaled
8.3. Oral

9. Americas Asthma Therapeutics Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Asthma Therapeutics Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Asthma Therapeutics Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. GSK Boosts Respiratory Portfolio with $1.4 Billion Aiolos Bio Acquisition
12.3.2. Teva and Biolojic Design Announce Exclusive License Agreement for the Development of a Therapeutic Antibody for Atopic Dermatitis and Asthma
12.3.3. Lupin Launches Luforbec® 100/6 for Adult Asthma and COPD Treatment

13. Competitive Portfolio

13.1. Key Company Profiles
13.2. Key Product Portfolio

List of Figures

FIGURE 1. ASTHMA THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. ASTHMA THERAPEUTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ASTHMA THERAPEUTICS MARKET DYNAMICS
FIGURE 7. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
FIGURE 10. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASTHMA THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. ASTHMA THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. ASTHMA THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY DRY POWDER INHALERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY DRY POWDER INHALERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY METERED-DOSE INHALERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY METERED-DOSE INHALERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY SOFT MIST INHALERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY SOFT MIST INHALERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY NEBULIZERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY BRONCHODILATORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY INHALED, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY INHALED, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL ASTHMA THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 36. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS ASTHMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 45. ARGENTINA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 46. ARGENTINA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 47. ARGENTINA ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 48. ARGENTINA ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 49. ARGENTINA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 50. ARGENTINA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 51. ARGENTINA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 52. ARGENTINA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 53. BRAZIL ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 54. BRAZIL ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 55. BRAZIL ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 56. BRAZIL ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 57. BRAZIL ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 58. BRAZIL ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 59. BRAZIL ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 60. BRAZIL ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 61. CANADA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 62. CANADA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 63. CANADA ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 64. CANADA ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 65. CANADA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 66. CANADA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 67. CANADA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 68. CANADA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 69. MEXICO ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 70. MEXICO ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 71. MEXICO ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 72. MEXICO ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 73. MEXICO ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 74. MEXICO ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 75. MEXICO ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 76. MEXICO ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 77. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 78. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 79. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 80. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 81. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 82. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 83. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 84. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 85. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 86. UNITED STATES ASTHMA THERAPEUTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 88. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 90. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 92. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 94. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 96. ASIA-PACIFIC ASTHMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 97. AUSTRALIA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 98. AUSTRALIA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 99. AUSTRALIA ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 100. AUSTRALIA ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 101. AUSTRALIA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 102. AUSTRALIA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 103. AUSTRALIA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 104. AUSTRALIA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 105. CHINA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 106. CHINA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 107. CHINA ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 108. CHINA ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 109. CHINA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 110. CHINA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 111. CHINA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 112. CHINA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 113. INDIA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 114. INDIA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 115. INDIA ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 116. INDIA ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 117. INDIA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 118. INDIA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 119. INDIA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 120. INDIA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 121. INDONESIA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 122. INDONESIA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 123. INDONESIA ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 124. INDONESIA ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 125. INDONESIA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 126. INDONESIA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 127. INDONESIA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 128. INDONESIA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 129. JAPAN ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 130. JAPAN ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 131. JAPAN ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 132. JAPAN ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 133. JAPAN ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 134. JAPAN ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 135. JAPAN ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 136. JAPAN ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 137. MALAYSIA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 138. MALAYSIA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 139. MALAYSIA ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 140. MALAYSIA ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 141. MALAYSIA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 142. MALAYSIA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 143. MALAYSIA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 144. MALAYSIA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 145. PHILIPPINES ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 146. PHILIPPINES ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 147. PHILIPPINES ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 148. PHILIPPINES ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 149. PHILIPPINES ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 150. PHILIPPINES ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 151. PHILIPPINES ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 152. PHILIPPINES ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 153. SINGAPORE ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 154. SINGAPORE ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 155. SINGAPORE ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 156. SINGAPORE ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 157. SINGAPORE ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 158. SINGAPORE ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 159. SINGAPORE ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 160. SINGAPORE ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 161. SOUTH KOREA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 162. SOUTH KOREA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 163. SOUTH KOREA ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 164. SOUTH KOREA ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 165. SOUTH KOREA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 166. SOUTH KOREA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 167. SOUTH KOREA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 168. SOUTH KOREA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 169. TAIWAN ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 170. TAIWAN ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 171. TAIWAN ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 172. TAIWAN ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 173. TAIWAN ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 174. TAIWAN ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 175. TAIWAN ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 176. TAIWAN ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 177. THAILAND ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 178. THAILAND ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 179. THAILAND ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 180. THAILAND ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 181. THAILAND ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 182. THAILAND ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 183. THAILAND ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 184. THAILAND ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 185. VIETNAM ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 186. VIETNAM ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 187. VIETNAM ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 188. VIETNAM ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 189. VIETNAM ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 190. VIETNAM ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 191. VIETNAM ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 192. VIETNAM ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 203. DENMARK ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 204. DENMARK ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 205. DENMARK ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 206. DENMARK ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 207. DENMARK ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 208. DENMARK ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 209. DENMARK ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 210. DENMARK ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 211. EGYPT ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 212. EGYPT ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 213. EGYPT ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 214. EGYPT ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 215. EGYPT ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 216. EGYPT ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 217. EGYPT ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 218. EGYPT ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 219. FINLAND ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 220. FINLAND ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 221. FINLAND ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 222. FINLAND ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 223. FINLAND ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 224. FINLAND ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 225. FINLAND ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 226. FINLAND ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 227. FRANCE ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 228. FRANCE ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 229. FRANCE ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 230. FRANCE ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 231. FRANCE ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 232. FRANCE ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 233. FRANCE ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 234. FRANCE ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 235. GERMANY ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 236. GERMANY ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 237. GERMANY ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 238. GERMANY ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 239. GERMANY ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 240. GERMANY ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 241. GERMANY ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 242. GERMANY ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 243. ISRAEL ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 244. ISRAEL ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 245. ISRAEL ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 246. ISRAEL ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 247. ISRAEL ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 248. ISRAEL ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 249. ISRAEL ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 250. ISRAEL ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 251. ITALY ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 252. ITALY ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 253. ITALY ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 254. ITALY ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 255. ITALY ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 256. ITALY ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 257. ITALY ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 258. ITALY ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 259. NETHERLANDS ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 260. NETHERLANDS ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 261. NETHERLANDS ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 262. NETHERLANDS ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 263. NETHERLANDS ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 264. NETHERLANDS ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 265. NETHERLANDS ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 266. NETHERLANDS ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 267. NIGERIA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 268. NIGERIA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 269. NIGERIA ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 270. NIGERIA ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 271. NIGERIA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 272. NIGERIA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 273. NIGERIA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 274. NIGERIA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 275. NORWAY ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 276. NORWAY ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 277. NORWAY ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 278. NORWAY ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 279. NORWAY ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 280. NORWAY ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 281. NORWAY ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 282. NORWAY ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 283. POLAND ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 284. POLAND ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 285. POLAND ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 286. POLAND ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 287. POLAND ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 288. POLAND ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 289. POLAND ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 290. POLAND ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 291. QATAR ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 292. QATAR ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 293. QATAR ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 294. QATAR ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 295. QATAR ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 296. QATAR ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 297. QATAR ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 298. QATAR ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 299. RUSSIA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 300. RUSSIA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 301. RUSSIA ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 302. RUSSIA ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 303. RUSSIA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 304. RUSSIA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 305. RUSSIA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 306. RUSSIA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 308. SAUDI ARABIA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 310. SAUDI ARABIA ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 312. SAUDI ARABIA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 314. SAUDI ARABIA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 316. SOUTH AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 318. SOUTH AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 320. SOUTH AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 322. SOUTH AFRICA ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 323. SPAIN ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 324. SPAIN ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 325. SPAIN ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 326. SPAIN ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 327. SPAIN ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 328. SPAIN ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 329. SPAIN ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 330. SPAIN ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 331. SWEDEN ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 332. SWEDEN ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 333. SWEDEN ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 334. SWEDEN ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 335. SWEDEN ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 336. SWEDEN ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 337. SWEDEN ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 338. SWEDEN ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 339. SWITZERLAND ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 340. SWITZERLAND ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 341. SWITZERLAND ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
TABLE 342. SWITZERLAND ASTHMA THERAPEUTICS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
TABLE 343. SWITZERLAND ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
TABLE 344. SWITZERLAND ASTHMA THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
TABLE 345. SWITZERLAND ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 346. SWITZERLAND ASTHMA THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 347. TURKEY ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 348. TURKEY ASTHMA THERAPEUTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 349. TURKEY ASTHMA THE

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Abbott Laboratories
Amgen Inc.
AstraZeneca PLC
Biogen Inc.
Boehringer Ingelheim GmbH
Boston Scientific Corporation
Chiesi Farmaceutici S.p.A.
Cipla Limited
F. Hoffmann-La Roche Ltd
Genentech, Inc.
GlaxoSmithKline PLC
Kare Medical and Analytical Devices Ltd. Co.
Koninklijke Philips N.V.
Lupin Limited
Medtronic PLC
Merck & Co, Inc.
Merxin Ltd.
Novartis AG
Parekhplast India Limited
Pfizer Inc.
Regeneron Pharmaceuticals, Inc.
Sanofi S.A.
Shenzhen Aeon Technology Co., Ltd.
Softhale NV by invoX Pharma Limited
Sun Pharmaceutical Industries Limited
Sunovion Pharmaceuticals, Inc.
Takeda Pharmaceutical Company
Teva Pharmaceutical Industries Ltd.
Trudell Medical Limited
Viatris Inc.
Wellinks, Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	195
Published	June 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 27.26 Billion
Forecasted Market Value ( USD ) by 2030	$ 50.1 Billion
Compound Annual Growth Rate	10.6%
Regions Covered	Global

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3712EUR$3,939USD£3,114GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€4664EUR$4,949USD£3,913GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6567EUR$6,969USD£5,510GBP

Global Asthma Therapeutics Market by Product (Inhalers, Nebulizers), Drug Class (Anti-Inflammatory, Bronchodilators, Combination Therapy), Route of administration - Forecast 2024-2030

Regional Insights

Market Insights

Market Dynamics

Market Drivers

Market Restraints

Market Opportunities

Market Challenges

Market Segmentation Analysis

Industry Insights

FPNV Positioning Matrix

Market Share Analysis

Recent Developments

GSK Boosts Respiratory Portfolio with $1.4 Billion Aiolos Bio Acquisition

Teva and Biolojic Design Announce Exclusive License Agreement for the Development of a Therapeutic Antibody for Atopic Dermatitis and Asthma

Lupin Launches Luforbec® 100/6 for Adult Asthma and COPD Treatment

Strategy Analysis & Recommendation

Key Company Profiles

Market Segmentation & Coverage

Product- Inhalers

Drug Class

Route of administration

Region

Americas

Asia-Pacific

Europe, Middle East & Africa

Table of Contents

Companies Mentioned (Partial List)

Methodology

Table Information

Regional Insights

Market Insights

Market Dynamics

Market Drivers

Market Restraints

Market Opportunities

Market Challenges

Market Segmentation Analysis

Industry Insights

FPNV Positioning Matrix

Market Share Analysis

Recent Developments

GSK Boosts Respiratory Portfolio with $1.4 Billion Aiolos Bio Acquisition

Teva and Biolojic Design Announce Exclusive License Agreement for the Development of a Therapeutic Antibody for Atopic Dermatitis and Asthma

Lupin Launches Luforbec® 100/6 for Adult Asthma and COPD Treatment

Strategy Analysis & Recommendation

Key Company Profiles

Market Segmentation & Coverage

Product- Inhalers

Drug Class

Route of administration

Region

Americas

Asia-Pacific

Europe, Middle East & Africa

Table of Contents

Companies Mentioned (Partial List)

Methodology

Table Information

Related Topics

Related Reports

Global Asthma Therapeutics Market Size, Share & Trends Analysis Report by Drug Class (Anti- inflammatory, Bronchodilators), Product (Inhalers, Nebulizers), Routeof Administration (Oral, Inhaled), Region, and Segment Forecasts, 2024-2030

Asthma Therapeutics Market Report by Drug Class, Product Type, Treatment Type, Route of Administration, and Region 2024-2032

Asthma Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

Asthma Therapeutics - Global Strategic Business Report

Allergic Asthma Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology

About the Asthma Treatment Market